Hostname: page-component-7b7567c8c-7pwfn Total loading time: 0 Render date: 2026-11-17T19:27:29.079Z Has data issue: false hasContentIssue false

Hypervigilance as a Specific Longitudinal Predictor of Anxiety Symptoms: A Self-Report Study

Published online by Cambridge University Press:  31 July 2026

C. Sorroche*
Affiliation:
Hospital Clínic de Barcelona
L. Prat-Torres
Affiliation:
Private Practice, Barcelona
P. Chavarría-Elizondo
Affiliation:
Institut d’Investigació Biomédica de Bellvitge, Hospitalet de LLobregat
V. De la Peña-Arteaga
Affiliation:
Institut de Recerca Sant Pau
I. Martínez-Zalacaín
Affiliation:
Institut d’Investigació Biomédica de Bellvitge, Hospitalet de LLobregat
A. Juaneda-Seguí
Affiliation:
Institut d’Investigació Biomédica de Bellvitge, Hospitalet de LLobregat
E. Vilajosana
Affiliation:
August Pi i Sunyer Biomedical Research Institute
J. Raduà
Affiliation:
August Pi i Sunyer Biomedical Research Institute
C. Soriano-Mas
Affiliation:
University of Barcelona, Barcelona, Spain
M. À. Fullana
Affiliation:
Hospital Clínic de Barcelona
*
*Corresponding author.

Abstract

Core share and HTML view are not available for this content. However, as you have access to this content, a full PDF is available via the 'Save PDF' action button.
Introduction

Hypervigilance is a distinctive attentional control state involving increased scanning of the environment to detect potential threats (Richards et al., Neurosci Biobehav Rev 2014; 47:102–117). Although it has been conceptually linked to anxiety, its specificity in predicting anxiety versus depressive symptoms remains unclear.

Objectives

This study aimed to examine the discriminant predictive validity of hypervigilance over time, assessing whether it serves as a specific longitudinal marker for anxiety symptoms compared to depressive symptoms.

Methods

A sample of 165 adults with varying levels of anxiety risk completed the Brief Hypervigilance Scale (BHS; Bernstein et al., Psychol Trauma 2015; 7:448–455) at baseline. Anxiety and depression symptoms were assessed six months later using the respective subscales of the Spanish version of the Depression Anxiety Stress Scales (DASS-21; Daza et al., J Psychopathol Behav Assess 2002; 24:195–205). Hierarchical regression analyses were conducted, controlling for age and baseline symptom levels.

Results

Hypervigilance significantly predicted anxiety symptoms at follow-up (β = .250, p = .003), accounting for an additional 4.1% of the variance beyond baseline anxiety. In contrast, its predictive value for depressive symptoms was non-significant (β = .119, p = .080). These findings suggest that hypervigilance may serve as a specific marker for anxiety vulnerability.

Conclusions

Self-reported hypervigilance demonstrates longitudinal specificity in predicting anxiety symptoms, but not depressive symptoms. These results support its potential utility in early identification and prevention strategies targeting anxiety disorders.

Disclosure of Interest

C. Sorroche: None Declared, L. Prat-Torres: None Declared, P. Chavarría-Elizondo: None Declared, V. De la Peña-Arteaga: None Declared, I. Martínez-Zalacaín: None Declared, A. Juaneda-Seguí: None Declared, E. Vilajosana: None Declared, J. Raduà Paid Instructor of: Dr. Raduà reports receiving continuing medical education honoraria from Inspira Networks for a machine learning course promoted by Adamed, outside the submitted work., C. Soriano-Mas: None Declared, M. À. Fullana: None Declared

Information

Type
Abstract
Creative Commons
Creative Common License - CCCreative Common License - BY
This is an Open Access article, distributed under the terms of the Creative Commons Attribution licence (https://creativecommons.org/licenses/by/4.0/), which permits unrestricted re-use, distribution, and reproduction in any medium, provided the original work is properly cited.
Copyright
© The Author(s), 2026. Published by Cambridge University Press on behalf of European Psychiatric Association
Submit a response

Comments

No Comments have been published for this article.